Covalent Proximity Scanning of a Distal Cysteine to Target PI3Kα-Reference-Cited by-同舟云学术

Covalent Proximity Scanning of a Distal Cysteine to Target PI3Kα

Published:2022-03-30 Issue:14 Volume:144 Page:6326-6342
ISSN:0002-7863
Container-title:Journal of the American Chemical Society
language:en
Short-container-title:J. Am. Chem. Soc.

Author:

Borsari Chiara¹^ORCID,Keles Erhan¹,McPhail Jacob A.²,Schaefer Alexander³,Sriramaratnam Rohitha¹,Goch Wojciech⁴,Schaefer Thorsten¹,De Pascale Martina¹^ORCID,Bal Wojciech⁵^ORCID,Gstaiger Matthias³,Burke John E.²^ORCID,Wymann Matthias P.¹^ORCID

Affiliation:

1. Department of Biomedicine, University of Basel, Mattenstrasse 28, 4058 Basel, Switzerland

2. Department of Biochemistry and Microbiology, University of Victoria, Victoria, British Columbia V8W 2Y2, Canada

3. Department of Biology, Institute of Molecular Systems Biology, ETH Zurich, Otto-Stern-Weg 3, 8093 Zürich, Switzerland

4. Department of Physical Chemistry, Faculty of Pharmacy, Medical University of Warsaw, 02-097 Warsaw, Poland

5. Institute of Biochemistry and Biophysics, Polish Academy of Sciences, 02-106 Warsaw, Poland

Funder

Schweizerischer Nationalfonds zur F?rderung der Wissenschaftlichen Forschung

Swiss Cancer Research Foundation

Peter und Traudl Engelhorn Stiftung

H2020 Health

Cancer Research Society

Michael Smith Foundation for Health Research

Stiftung f?r Krebsbek?mpfung

Publisher

American Chemical Society (ACS)

Subject

Colloid and Surface Chemistry,Biochemistry,General Chemistry,Catalysis

Link

https://pubs.acs.org/doi/pdf/10.1021/jacs.1c13568

Reference83 articles.

1. Afatinib versus placebo for patients with advanced, metastatic non-small-cell lung cancer after failure of erlotinib, gefitinib, or both, and one or two lines of chemotherapy (LUX-Lung 1): a phase 2b/3 randomised trial

2. Discovery of Selective Irreversible Inhibitors for Bruton’s Tyrosine Kinase

3. Osimertinib (AZD9291)—a science-driven, collaborative approach to rapid drug design and development

4. Dacomitinib in the Management of Advanced Non-Small-Cell Lung Cancer

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted Covalent Inhibitors in Drug Discovery, Chemical Biology and Beyond;Pharmaceuticals;2024-02-05

2. Expanding the ligandable proteome by paralog hopping with covalent probes;2024-01-20

3. A high affinity pan-PI3K binding module supports selective targeted protein degradation of PI3Kα;Chemical Science;2024

4. Covalent inhibitors: An ambitious approach for the discovery of newer oncotherapeutics;Drug Development Research;2023-12-06

5. Development of covalent inhibitors: Principle, design, and application in cancer;MedComm – Oncology;2023-10-31